Darvon
Quick Facts
Darvon Reference Guide
Generic Name
Propoxyphene
Acetaminophen
Date Approved
July 26, 2002
Manufacturer
Aaipharma LLC
Status
On the market
Approved Uses
Relief of pain
Serious Side Effects
Suicide
Death
Lightheadedness
Dizziness
Sedation
Nausea
Vomiting
Related Topics
Darvocet
Defective Drugs
Propoxyphene
Acetaminophen
Date Approved
July 26, 2002
Manufacturer
Aaipharma LLC
Status
On the market
Approved Uses
Relief of pain
Serious Side Effects
Suicide
Death
Lightheadedness
Dizziness
Sedation
Nausea
Vomiting
Related Topics
Darvocet
Defective Drugs
Injured by Darvon?
Public Citizen’s Health Research Group asked the FDA on February 28, 2006 to ban Darvon and Darvocet, two popular painkillers. Darvon and Darvocet have been associated with the deaths of at least 2,110 people between 1981 and 1999. Additionally, Public Citizen’s Health Research Group said several hundred more people have died accidentally after taking the drugs each year since then. Dr. Sidney Wolfe, the group’s director, said the main active ingredient in the drugs, propoxyphene, is a relatively weak painkiller and poses an unacceptable toxic risk to the millions of patients prescribed it each year. It’s been sold since 1957. The drug’s popularity has waned, but still doctors wrote 23 million prescriptions for propoxyphene-containing drugs last year. Darvocet, which combines propoxyphene with acetaminophen, is among the best known of these types of painkillers.An analysis of 26 studies that compared propoxyphene and acetaminophen with just acetaminophen or a dummy pill found the “narcotic combination offered little benefit over acetaminophen alone” in treating pain. “Thus, propoxyphene provides minimal if any additional analgesia to acetaminophen alone and is associated with significant adverse effects. It cannot be recommended for routine use,” Dr. Carolyn Sachs of the University of California, Los Angeles, wrote in her analysis, published in March 2005 in American Family Physician.
Co-proxamol, Britain’s most frequently used drug, has been taken off the market due to concerns about the high risk of accidental death from slight overdose and its frequent use in suicides. Co-proxamol is prescribed to hundreds of thousands of people every year has been the subject of a staggered withdrawal because of evidence that it can cause death if patients exceed the maximum recommended dosage by as little as two tablets. As many as 400 deaths a year are linked to either accidental or intentional overdoses of co-proxamol.
A recent study found that the medication, whose effects are increased by alcohol, was responsible for 18 percent of all drug-related deaths and 5 percent of all suicides. As late 1997, it was the second most prescribed drug after the antibiotic amoxycilin. It is currently marketed by several pharmaceutical companies as co-proxamol and it is also sold under the brand names Distalgesic, Cosalgesic and Dolgesic. In the United States the drug is sold under the names Darvocet and Darvon.
If you or a loved one has taken Darvon and experienced suicidal thoughts or committed suicide, contact us for a free case evaluation about your case today. Please fill out the short form at the right, or call our lawyers at 1-800-LAW-INFO (1-800-529-4636).
DarvonRSS Feed
Darvon, Similar Painkillers to Have Stronger Overdose Warnings
Jul 7, 2009 | Parker Waichman Alonso LLP
The makers of Darvon, Darvocet and other painkillers that contain propoxyphene are being required to strengthen the drugs' labels, including their boxed warning, to emphasize the potential for overdose. However, the Food & Drug Administration (FDA) has rejected a petition from a consumer advocacy group to remove Darvon and similar drugs from the market.Propoxyphene has been on the market since 1957. It is a widely prescribed member of a group of drugs known as opioids and is...
Fate of Darvon, Davocet to Be Discussed
Jan 30, 2009 | Parker Waichman Alonso LLP
The popular painkillers Darvon and Darvocet might be removed form the market. The U.S. Food and Drug Administration (FDA) has convened an expert medical panel to make a recommendation regarding the fate of the two popular pain pills, reported Dow Jones. Over 20 million prescriptions for the drugs have been written since 2007, said the FDA.Eli Lilly & Company’s Darvon, contains the active ingredient propoxyphene and has been on the U.S. market for over 50 years, said Dow...
Group Wants FDA to Ban Painkiller
Jun 20, 2008 | Parker Waichman Alonso LLP
Propoxyphene, the addictive prescription painkiller sold under names that include Darvon and Darvocet is too risky to stay on the market, says Public Citizen, a consumer advocacy group suing the US Food and Drug Administration (FDA).Pubic Citizen petitioned the FDA two years ago to ban Propoxyphene saying it was not any more effective than other, safer painkillers and pointing to at least 2,110 accidental deaths between 1981 and 1999. Several hundred more accidental deaths have been...
Consumer Watchdog Group, Public Citizen, Petitions FDA to Ban All Darvon Products
Mar 1, 2006 | Newsinferno News Staff
Public Citizen “a national, nonprofit consumer advocacy organization founded in 1971 to represent consumer interests in Congress, the executive branch and the courts” has filed a lengthy formal petition: (http://www.citizen.org/publications/release.cfm?ID=7420) with the Food and Drug Administration “pursuant to the Federal Food, Drug and Cosmetic Act 21, U.S.C. Section 355(e)(3), and 21 C.F.R. 10.30 to immediately begin the phased removal from the market of propoxyphene...
Group petitions FDA to ban pain drug
Feb 28, 2006 | AP
Darvon, Darvocet and related painkillers were associated with the deaths of at least 2,110 people between 1981 and 1999, critics said Tuesday in asking the government to ban the drugs.Several hundred more people have died accidentally after taking the drugs each year since then, Public Citizen’s Health Research Group said in a petition it planned to submit to Food and Drug Administration acting Commissioner Dr. Andrew von Eschenbach.Dr. Sidney Wolfe, the group’s director, said the...
